The University of Notre Dame is dedicated to tackling the complex challenges of non-communicable diseases (NCDs) that impact both our local and global communities. As Notre Dame’s global health leader, the Eck Institute for Global Health drives innovation by linking fundamental insights into genetics, physiology, and pathology, with efforts to confront the root causes of disease. Our research portfolio spans cancer, mental health, and nutrition, reflecting the breadth and urgency of this work.

Confronting NCDs is central to Notre Dame's mission to promote health equity and improve outcomes for marginalized and underserved populations both locally and globally. By prioritizing the needs of resource-challenged communities and fostering reciprocal partnerships, we assist to drive innovations with broad and lasting health benefits. This approach not only advances. health equity but also strengthens community resilience.

Supporting local capacity and tailoring solutions to diverse contexts helps communities prepare for and respond to future challenges. In doing so, our efforts contribute to global health, well-being, and stability by ensuring that even the most vulnerable populations are better equipped to face ongoing and emerging health issues.

Non-Communicable Disease Research Update

Our advanced research in non-communicable diseases takes place in communities all over the world. 

Meet Our NCD Researchers View Our NCD Research Projects

 

 

A young woman wearing a dark red hijab smiles in a cafeteria with rows of wooden tables and metal cups and plates containing food.

Media Mentions

View all media mentions
  1. How do we adapt to the cold?

    And we speak to Dr Cara Ocobock (~19 minute mark), affiliate faculty member of the Eck Institute for Global Health at the University of Notre Dame, USA, who tells us about her research comparing Finnish reindeer herders and office workers reactions to cold temperatures.

  2. Measuring tumor force offers new clues for brain cancer treatment

    Now, the same team of researchers from the University of Notre Dame, Harvard Medical School/Massachusetts General Hospital, and Boston University has developed a technique for measuring a brain tumor's mechanical force and a new model to estimate how much brain tissue a patient has lost. 

  3. One in six cancer medications fails safety standards in sub-Saharan Africa

    “It is important that cancer medications contain the right amount of the active ingredients so the patient gets the correct dose,” said Marya Lieberman, professor of chemistry and biochemistry at Notre Dame and lead author of the study. “If the patient’s dose is too small, the cancer can survive and spread to other locations. If the patient’s dose is too high, they can be harmed by toxic side effects from the medicine.”